Skip to content

Patients with myelofibrosis and anemia respond to antihemojuvelin drug
John Mascarenhas, MD, discusses the phase 3 SENTRY trial
Which AML patients get lasting benefit from olutasidenib?
Dr. Marc Hoffman discusses results from the GOLSEEK-1 trial of golcadomide in frontline ABCL
Anito-cel manufacturing builds on CAR T-cell learnings in multiple myeloma trials

Insider Reader Survey

Join SOHO

Insider Podcast
Society Updates
Resources
Hem/Onc Library
- Current Issue
  - Past Issues
- Cellular Therapy
- Leukemia
  - ALL
  - AML
  - CLL
  - CML
- Lymphoma
  - ABCL
  - IBCL
  - MCL
  - TCL
- MDS
- MPN
- Multiple Myeloma
Community Oncology
- Past Sessions
Meeting News
Multimedia
- Roundtable Discussions
- Video Interviews
Subscribe

About Us

The Society of Hematologic Oncology (SOHO) was established as a non-profit corporation in 2012 with aims to promote worldwide research, education, prevention, clinical studies and optimal patient care in all aspects of hematologic malignancies and related disorders.

Join SOHO

Lymphoma

Lymphoma News SOHO 2025 Lymphoma Mantle Cell Lymphoma SOHO Insider Podcast

Drs. Melody, Phillips talk glofitamab in MCL

by Leah Sherwood
January 30, 2026
0 Comments

Lymphoma News SOHO 2025 News

BTK ‘degrader’ bexdeg shines in Waldenström macroglobulinemia

by SOHO Insider Editors
October 3, 2025
0 Comments

Lymphoma News SOHO 2025 Meetings / Conferences Video Interviews

Dr. Kantarjian interviews Dr. Graff on MorningSun trial at SOHO 2025

by Leah Sherwood
September 30, 2025
0 Comments

Lymphoma News Leukemia News SOHO 2025 News Young Investigator Program

Next-gen hem/oncs engage in new CLL/SLL educational pilot program at SOHO 2025

by SOHO Insider Editors
September 24, 2025
0 Comments

hand of a lab technician holding blood tube test and background a rack of color tubes with blood samples other patients / laboratory technician holding a blood tube test

Lymphoma News SOHO 2025 Meetings / Conferences

B-, T-cell lymphoma diagnostic test launched at SOHO 2025

by SOHO Insider Editors
September 22, 2025
0 Comments

Lymphoma News SOHO 2025 Cellular Therapy News Video Interviews

Dr. Karmali discusses phase 2 TRANSCEND FL study results

by Leah Sherwood
September 16, 2025
0 Comments

World heart day, volunteering and charity. Millennial african-american man holding red heart on his chest, free space

Lymphoma News SOHO 2025 News

Should heart health get more attention in WM patients?

by SOHO Insider Editors
September 15, 2025
0 Comments

Lymphoma News SOHO 2025 News

Megan Melody on HL and MCL research at SOHO 2025

by SOHO Insider Editors
September 6, 2025
0 Comments

Lymphoma News SOHO 2025 Meetings / Conferences News

Today’s Next Questions session explores the “shift” in treatment for Hodgkin lymphoma

by sohonews
September 6, 2025
0 Comments

Lymphoma News SOHO 2025 News

Jennifer R. Brown, MD, PhD, honored with Michael J. Keating Outstanding Achievement Award

by Leah Sherwood
September 4, 2025
0 Comments

1
2

Top Categories

Cellular Therapy

74

Leukemia

113

Lymphoma

128

Multiple Myeloma

97

Myelodysplastic Syndromes

39

Myeloproliferative Neoplasms

24

POPULAR NEWS

The Society of Hematologic Oncology (SOHO) was established as a non-profit corporation in 2012 with aims to promote worldwide research, education, prevention, clinical studies and optimal patient care in all aspects of hematologic malignancies and related disorders.

About Us

Categories

Cellular Therapy

Leukemia

Lymphoma

Multiple Myeloma

Myelodysplastic Syndromes

Myeloproliferative Neoplasms

Contact Info

Lymphoma

Drs. Melody, Phillips talk glofitamab in MCL

BTK ‘degrader’ bexdeg shines in Waldenström macroglobulinemia

Dr. Kantarjian interviews Dr. Graff on MorningSun trial at SOHO 2025

Next-gen hem/oncs engage in new CLL/SLL educational pilot program at SOHO 2025

B-, T-cell lymphoma diagnostic test launched at SOHO 2025

Dr. Karmali discusses phase 2 TRANSCEND FL study results

Should heart health get more attention in WM patients?

Megan Melody on HL and MCL research at SOHO 2025

Today’s Next Questions session explores the “shift” in treatment for Hodgkin lymphoma

Jennifer R. Brown, MD, PhD, honored with Michael J. Keating Outstanding Achievement Award

About

About Us / Editorial Board

Advertising

Contact Us

Support SOHO

Categories

Cellular Therapy

Leukemia

Lymphoma

Multiple Myeloma

Myelodysplastic Syndromes

Myeloproliferative Neoplasms

Recent Posts

Patients with myelofibrosis and anemia respond to antihemojuvelin drug

John Mascarenhas, MD, discusses the phase 3 SENTRY trial

Which AML patients get lasting benefit from olutasidenib?

About Us

Categories

Cellular Therapy

Leukemia

Lymphoma

Multiple Myeloma

Myelodysplastic Syndromes

Myeloproliferative Neoplasms

Contact Info

Follow Us

Lymphoma

About

About Us / Editorial Board

Advertising

Contact Us

Support SOHO

Cellular Therapy

Leukemia

Lymphoma

Multiple Myeloma

Myelodysplastic Syndromes

Myeloproliferative Neoplasms